Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Nefazodone treatment of cocaine dependence with comorbid depressive symptoms.

Ciraulo DA, Knapp C, Rotrosen J, Sarid-Segal O, Ciraulo AM, LoCastro J, Greenblatt DJ, Leiderman D.

Addiction. 2005 Mar;100 Suppl 1:23-31.

PMID:
15730347
2.

Nefazodone. A review of its pharmacology and clinical efficacy in the management of major depression.

Davis R, Whittington R, Bryson HM.

Drugs. 1997 Apr;53(4):608-36. Review.

PMID:
9098663
3.

Nefazodone: a new antidepressant.

Ellingrod VL, Perry PJ.

Am J Health Syst Pharm. 1995 Dec 15;52(24):2799-812. Review.

PMID:
8748566
4.

[Efficacy and tolerability of escitalopram in anxiety disorders: a review].

Pelissolo A.

Encephale. 2008 Sep;34(4):400-8. doi: 10.1016/j.encep.2008.04.004. Epub 2008 Aug 15. Review. French.

PMID:
18922243
5.

Comparative benefits and harms of second-generation antidepressants: background paper for the American College of Physicians.

Gartlehner G, Gaynes BN, Hansen RA, Thieda P, DeVeaugh-Geiss A, Krebs EE, Moore CG, Morgan L, Lohr KN.

Ann Intern Med. 2008 Nov 18;149(10):734-50. Review.

PMID:
19017592
6.

Cost savings with nefazodone in treating depression.

Hales RE, Hilty DM, Brunson GH.

J Clin Psychiatry. 2002;63 Suppl 1:48-51. Review.

7.

Pharmacology of antidepressants: focus on nefazodone.

DeVane CL, Grothe DR, Smith SL.

J Clin Psychiatry. 2002;63 Suppl 1:10-7. Review.

8.

Treatment of cocaine dependence and depression.

Rounsaville BJ.

Biol Psychiatry. 2004 Nov 15;56(10):803-9. Review.

PMID:
15556126
9.
10.

Clinical use of nefazodone in major depression: a 6-year perspective.

Schatzberg AF, Prather MR, Keller MB, Rush AJ, Laird LK, Wright CW.

J Clin Psychiatry. 2002;63 Suppl 1:18-31. Review. No abstract available.

11.

Six-year perspectives on the safety and tolerability of nefazodone.

Dunner DL, Laird LK, Zajecka J, Bailey L, Sussman N, Seabolt JL.

J Clin Psychiatry. 2002;63 Suppl 1:32-41. Review. No abstract available.

12.

Nefazodone: its place among antidepressants.

Cyr M, Brown CS.

Ann Pharmacother. 1996 Sep;30(9):1006-12. Review.

PMID:
8876863
13.

Implications of recent research for program quality in cocaine dependence treatment.

Carroll KM.

Subst Use Misuse. 2000 Oct-Dec;35(12-14):2011-30. Review.

PMID:
11138715
14.

The use of monoamine pharmacological agents in the treatment of sexual dysfunction: evidence in the literature.

Moll JL, Brown CS.

J Sex Med. 2011 Apr;8(4):956-70. doi: 10.1111/j.1743-6109.2010.02190.x. Epub 2011 Jan 27. Review.

PMID:
21272265

Supplemental Content

Support Center